India Losartan Market to be dominated by hypertension segment in FY2026
Growing prevalence of hypertension
is expected to drive the growth of India Losartan market.
According to
TechSci Research report, “India Losartan Market By Source (In-house v/s
Contract Manufacturing Organizations), By Form (Tablet, Capsule, Others), By
Strength (25 mg, 50 mg, 100 mg, Others), By Distribution Channel (Online v/s
Offline), By Application (Hypertension, Stroke, Diabetic Nephropathy, Others), By
End User (Adult v/s Paediatric), By Company, By Region, Forecast &
Opportunities, FY2026”, the India losartan market is
expected to grow at a steady rate during the forecast period. Losartan is an
angiotensin II receptor blocker and is available as losartan potassium oral
tablets as well as a combination tablet of losartan potassium and
hydrochlorothiazide. The consumption of Losartan also delay progression of
diabetic nephropathy which is expected to fuel the market growth through FY2026.
However, side-effects associated with drug consumption such as delayed
progression of diabetic nephropathy can restrict the market growth over the
next few years. Moreover, the use of this drug is prohibited for the people who
are diabetic and taking aliskiren. Along with this, patients suffering from
type 2 diabetes and kidney disease may experience diarrhea, low blood pressure,
fatigue, low blood glucose, chest pain, elevated potassium, or allergic
reaction. This can further reduce the usage and application of the drug thereby
hindering the market growth during the forecast period.
Browse XX market data Tables and XX Figures spread
through XXX Pages and an in-depth TOC on" India Losartan Market"
https://www.techsciresearch.com/report/india-losartan-market/5162.html
The India
losartan market is segmented based on source, form, strength, distribution channel,
application, end user, company, and region. Based on application, the
market can be fragmented into hypertension, stroke, diabetic nephropathy,
others. The hypertension segment is expected to dominate the market in the
forthcoming years on account of rising count of patients having high blood
pressure problems in the country. Based on source, the market can be
categorized into in-house v/s contract manufacturing organizations. The in-house
segment dominated the market until 2017 due to the fact that in-house
manufacturing is often a more cost-effective avenue, in particular for the
companies that manufacture highly customized products. In terms of form, the
market is split into tablet, capsule, others. Among them, the capsule segment
is projected to grow at a high rate in the next 5 years on account of multiple
benefits it provides such as capsules break down more quickly than tablets.
Also, they offer faster relief from symptoms when compared to tablets. This is
further contributing to its fast growing CAGR in the years to come.
Alembic
Pharmaceuticals Ltd, Torrent Pharmaceutical Ltd., Lupin Ltd., Teva API India
Ltd., Novartis India Ltd., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd.,
Sun Pharmaceuticals Industries Ltd., Taj Pharmaceuticals Ltd., Anuh Pharma Ltd. and others are
some of the leading players operating in India losartan market.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5162
Customers can
also request for 10% free customization on this report.
“India Losartan market is
expected to witness growth during the forecast period as it is used to treat hypertensive
patients with left ventricular hypertrophy. Further, it
reduces the risk
of stroke in patients having high blood pressure problems which is further
expected to create lucrative opportunities for the market growth of India Losartan
market over the next five years.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based India management consulting firm.
“India Losartan Market By Source (In-house v/s
Contract Manufacturing Organizations), By Form (Tablet, Capsule, Others), By
Strength (25 mg, 50 mg, 100 mg, Others), By Distribution Channel (Online v/s
Offline), By Application (Hypertension, Stroke, Diabetic Nephropathy, Others), By
End User (Adult v/s Paediatric), By Company, By Region, Forecast &
Opportunities, FY2026”, has evaluated
the future growth potential of India losartan market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges and
opportunities in India losartan market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]